Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on May 26, 2018 11:57pm
263 Views
Post# 28085395

RE:what I have learned after 20 years as a shareholder

RE:what I have learned after 20 years as a shareholderRapid, you wrote: "4. On a business front a company the size of PLI in no way should be going it alone, and as such have alienated many large pharma companies from participating in our success, hence the shareholders success! We should have merged the entire company 12 years ago when competitive offers were in the billions!! . I am told that it is likely the same large pharma’s will continue to punish the share price strategically."

How do you know there were "
competitive offers were in the billions"?
Bullboard Posts